Pfizer and Voyager Agree to Develop Neurologic and Cardiovascular Gene Therapies Valued at up to $630 Million
Abbvie and Regenexbio Agree to Develop and Commercialize Eye Disease Gene Therapy
Chinese Patent Linkage, Patent Term Adjustment, and Patent Term Extension Guidelines Unveiled For Comments
American Gene Technologies Celebrates Milestone in HIV Cure Development
Prime Medicine Emerges with $315 Million to Develop Next Generation Gene Editing Platform
‘The Sky is [Not] Falling,’ Federal Circuit Urges as it Continues to Dismantle Broad Pharmaceutical Patents
A Framework for Protecting Your Invention Outside the U.S.
Patent Term Extension Introduced by the Fourth Amendment to the Chinese Patent Law
